Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Inventory (2023 - 2025)

Historic Change in Inventory for Krystal Biotech (KRYS) over the last 3 years, with Q3 2025 value amounting to $4.7 million.

  • Krystal Biotech's Change in Inventory rose 2814.03% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 9988.09%. This contributed to the annual value of $11.9 million for FY2024, which is 16607.82% up from last year.
  • As of Q3 2025, Krystal Biotech's Change in Inventory stood at $4.7 million, which was up 2814.03% from -$880000.0 recorded in Q2 2025.
  • Krystal Biotech's 5-year Change in Inventory high stood at $6.5 million for Q4 2024, and its period low was -$880000.0 during Q2 2025.
  • Moreover, its 3-year median value for Change in Inventory was $1.8 million (2024), whereas its average is $2.2 million.
  • Within the past 5 years, the most significant YoY rise in Krystal Biotech's Change in Inventory was 122540.65% (2024), while the steepest drop was 15849.89% (2024).
  • Over the past 3 years, Krystal Biotech's Change in Inventory (Quarter) stood at $492000.0 in 2023, then soared by 1225.41% to $6.5 million in 2024, then decreased by 27.73% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, -$880000.0 for Q2 2025, and $1.4 million during Q1 2025.